Prognostic significance of programmed death-1 and programmed death ligand-1 proteins in breast cancer-Reference-Cited by-同舟云学术

Prognostic significance of programmed death-1 and programmed death ligand-1 proteins in breast cancer

Published:2022-08-26 Issue:3 Volume:30 Page:131-150
ISSN:1875-869X
Container-title:Human Antibodies
language:
Short-container-title:HAB

Author:

Tahir Imtiaz Mahmood¹,Rauf Abdur²,Mehboob Huma³,Sadaf Samia⁴,Alam Muhammad Shaiful⁵,Kalsoom Fadia¹,Bouyahya Abdelhakim⁶,El Allam Aicha⁶,El Omari Nasreddine⁷,Bakrim Saad⁸,Akram Muhammad⁹,Raza Syed Kashif¹,Emran Talha Bin¹⁰¹¹,Mabkhot Yahia N.¹²,Zengin Gokhan¹³,Derkho Marina¹⁴,Natalya Suray¹⁵,Shariati Mohammad Ali¹⁵

Affiliation:

1. College of Allied Health Professionals, Government College University, Faisalabad, Pakistan

2. Department of Chemistry, University of Swabi, KPK, Pakistan

3. Department of Biochemistry, Government College Women University, Faisalabad, Pakistan

4. Department of Genetic Engineering and Biotechnology, University of Chittagong, Chittagong, Bangladesh

5. Department of Pharmacy, University of Science and Technology Chittagong, Chittagong, Bangladesh

6. Laboratory of Human Pathologies Biology, Department of Biology, Faculty of Sciences, Mohammed V University in Rabat, Morocco

7. Laboratory of Histology, Embryology, and Cytogenetics, Faculty of Medicine and Pharmacy, Mohammed V University, Rabat, Morocco

8. Geo-Bio-Environment Engineering and Innovation Laboratory, Molecular Engineering, Biotechnologies and Innovation Team, Polydisciplinary Faculty of Taroudant, Ibn Zohr University, Agadir, Morocco

9. Department of Eastern Medicine, Government College University Faisalabad Pakistan, Faisalabad, Pakistan

10. Department of Pharmacy, BGC Trust University Bangladesh, Chittagong, Bangladesh

11. Department of Pharmacy, Faculty of Allied Health Sciences, Daffodil International University, Dhaka, Bangladesh

12. Department of Pharmaceutical Chemistry, College of Pharmacy, King Khalid University, Abha, Saudi Arabia

13. Department of Biology, Science Faculty, Selcuk University, Konya, Turkey

14. South-Urals State Agrarian University, Troitsk, Chelyabinsk Region, Russia

15. K.G. Razumovsky Moscow State University of Technologies and Management (The First Cossack University), Moscow, Russia

Abstract

In numerous studies related to tumor prognosis, programmed death-ligand 1 (PD-L1) has been identified as a biomarker. This work aimed to determine the prognostic importance of PD-L1 in breast cancer. We searched electronic databases such as PubMed, Google scholar, home pages of publishing groups, medical, clinical, and pharmaceutical sciences journals, as well as other relevant sources to discover the importance of PD-1 and PD-L1 expression in breast cancer therapies and also recurrence. The keywords used in this search were autoimmunity, programmed cell death, PD-L1 or PD-1, and breast cancer. Our inclusion criteria included studies showing the synergy between the expression of PD-L1 and PD-1 in primary breast cancers as prognostic markers and this research was limited to humans only. We included review articles, original research, letters to the editor, case reports, and short communications in our study, published in English. We focused our work on PD-L1 mRNA expression in breast cancer cell lines. PD-L1 expression has been decisively demonstrated to be a high-risk factor for breast cancer with a bad prognosis.

Publisher

IOS Press

Subject

General Medicine,Immunology,Immunology and Allergy

Reference196 articles.

1. Vaccine and antibody-directed T cell tumour immunotherapy;Dermime;Biochim Biophys Acta BBA – Rev Cancer,2004

2. Clonal expansion versus functional clonal inactivation: A costimulatory signalling pathway determines the outcome of T cell antigen receptor occupancy;Mueller;Annu Rev Immunol,1989

3. Bour-Jordan Intrinsic and extrinsic control of peripheral T-cell tolerance by costimulatory molecules of the CD28/B7 family, Immunological Reviews;Hélène;Wiley Online Library,2011

4. Structural and functional analysis of the costimulatory receptor programmed death-1;Zhang;Immunity,2004

5. Regulation of immune responses through inhibitory receptors;Long;Annu Rev Immunol,1999